Observation on clinical effect of Huoxue-Jiangtang decoction formula granules in treating prediabetes: a randomized prospective placebo-controlled double-blind trial protocol

Abstract Background Prediabetes is a hypermetabolic syndrome with blood sugar levels falling between the normal and diabetes. People with prediabetes have a significantly increased chances of developing diabetes, cardiovascular and cerebrovascular diseases, tumors, dementia, and other diseases in th...

Full description

Bibliographic Details
Main Authors: Peng-Xiang Zhang, Lin Zeng, Lu Meng, Hui-Lin Li, Heng-Xia Zhao, De-Liang Liu
Format: Article
Language:English
Published: BMC 2022-10-01
Series:BMC Complementary Medicine and Therapies
Subjects:
Online Access:https://doi.org/10.1186/s12906-022-03755-2
_version_ 1811336275666403328
author Peng-Xiang Zhang
Lin Zeng
Lu Meng
Hui-Lin Li
Heng-Xia Zhao
De-Liang Liu
author_facet Peng-Xiang Zhang
Lin Zeng
Lu Meng
Hui-Lin Li
Heng-Xia Zhao
De-Liang Liu
author_sort Peng-Xiang Zhang
collection DOAJ
description Abstract Background Prediabetes is a hypermetabolic syndrome with blood sugar levels falling between the normal and diabetes. People with prediabetes have a significantly increased chances of developing diabetes, cardiovascular and cerebrovascular diseases, tumors, dementia, and other diseases in the future when compared to the healthy population. However, prediabetes is mainly treated based on lifestyle intervention, currently without targeted drug treatment plan. Traditional Chinese medicine (TCM), which has a longstanding experience, has been shown in clinical studies to be effective for the treatment of diabetes and its related complications. Furthermore, different dosage forms such as decoction and granule have developed gradually in clinical application. Preliminary studies have found that Huoxue-Jangtang Decoction (HJD), with good hypoglycemic and lipid-regulating effects, is potentially one of the complementary and alternative treatments for prediabetes. Therefore, this project intends to perform a prospective clinical study to observe the clinical effectiveness of HJD on prediabetes and the consistency of the efficacy of formula granules and the elixation. Methods This is a prospective, randomized, double-blind, and placebo-controlled clinical trial. A total of 183 participants are randomly assigned to HJD Formula Granules plus lifestyle intervention, HJD Elixation plus lifestyle intervention, and placebo plus lifestyle intervention. All subjects undergo 1 day of screening before participating in the study, followed by 84 days of drug intervention and observation. During and after treatment, the main outcome measures include fasting blood glucose and 2-hour postprandial blood glucose. Discussion This research attempts to verify the clinical efficacy and possible mechanism of HJD in the treatment of prediabetes, and prove the consistency of HJD Formula Granules with HJD Elixation. This study also aims to provide a treatment that is both effective and safe for prediabetic patients. Trial registration ClinicalTrials.gov Identifier: ChiCTR2200060813, Registered 12 June 2022.
first_indexed 2024-04-13T17:37:04Z
format Article
id doaj.art-889cb0b6520b4a89b2133fc59e0d830d
institution Directory Open Access Journal
issn 2662-7671
language English
last_indexed 2024-04-13T17:37:04Z
publishDate 2022-10-01
publisher BMC
record_format Article
series BMC Complementary Medicine and Therapies
spelling doaj.art-889cb0b6520b4a89b2133fc59e0d830d2022-12-22T02:37:19ZengBMCBMC Complementary Medicine and Therapies2662-76712022-10-0122111210.1186/s12906-022-03755-2Observation on clinical effect of Huoxue-Jiangtang decoction formula granules in treating prediabetes: a randomized prospective placebo-controlled double-blind trial protocolPeng-Xiang Zhang0Lin Zeng1Lu Meng2Hui-Lin Li3Heng-Xia Zhao4De-Liang Liu5The Fourth Clinical Medical College of Guangzhou University of Chinese MedicineThe Fourth Clinical Medical College of Guangzhou University of Chinese MedicineThe Fourth Clinical Medical College of Guangzhou University of Chinese MedicineShenzhen Traditional Chinese Medicine HospitalEndocrinology Department of Shenzhen Traditional Chinese Medicine HospitalEndocrinology Department of Shenzhen Traditional Chinese Medicine HospitalAbstract Background Prediabetes is a hypermetabolic syndrome with blood sugar levels falling between the normal and diabetes. People with prediabetes have a significantly increased chances of developing diabetes, cardiovascular and cerebrovascular diseases, tumors, dementia, and other diseases in the future when compared to the healthy population. However, prediabetes is mainly treated based on lifestyle intervention, currently without targeted drug treatment plan. Traditional Chinese medicine (TCM), which has a longstanding experience, has been shown in clinical studies to be effective for the treatment of diabetes and its related complications. Furthermore, different dosage forms such as decoction and granule have developed gradually in clinical application. Preliminary studies have found that Huoxue-Jangtang Decoction (HJD), with good hypoglycemic and lipid-regulating effects, is potentially one of the complementary and alternative treatments for prediabetes. Therefore, this project intends to perform a prospective clinical study to observe the clinical effectiveness of HJD on prediabetes and the consistency of the efficacy of formula granules and the elixation. Methods This is a prospective, randomized, double-blind, and placebo-controlled clinical trial. A total of 183 participants are randomly assigned to HJD Formula Granules plus lifestyle intervention, HJD Elixation plus lifestyle intervention, and placebo plus lifestyle intervention. All subjects undergo 1 day of screening before participating in the study, followed by 84 days of drug intervention and observation. During and after treatment, the main outcome measures include fasting blood glucose and 2-hour postprandial blood glucose. Discussion This research attempts to verify the clinical efficacy and possible mechanism of HJD in the treatment of prediabetes, and prove the consistency of HJD Formula Granules with HJD Elixation. This study also aims to provide a treatment that is both effective and safe for prediabetic patients. Trial registration ClinicalTrials.gov Identifier: ChiCTR2200060813, Registered 12 June 2022.https://doi.org/10.1186/s12906-022-03755-2PrediabetesHuoxue Jiangtang formulaRandomized controlled trialTraditional Chinese medicine
spellingShingle Peng-Xiang Zhang
Lin Zeng
Lu Meng
Hui-Lin Li
Heng-Xia Zhao
De-Liang Liu
Observation on clinical effect of Huoxue-Jiangtang decoction formula granules in treating prediabetes: a randomized prospective placebo-controlled double-blind trial protocol
BMC Complementary Medicine and Therapies
Prediabetes
Huoxue Jiangtang formula
Randomized controlled trial
Traditional Chinese medicine
title Observation on clinical effect of Huoxue-Jiangtang decoction formula granules in treating prediabetes: a randomized prospective placebo-controlled double-blind trial protocol
title_full Observation on clinical effect of Huoxue-Jiangtang decoction formula granules in treating prediabetes: a randomized prospective placebo-controlled double-blind trial protocol
title_fullStr Observation on clinical effect of Huoxue-Jiangtang decoction formula granules in treating prediabetes: a randomized prospective placebo-controlled double-blind trial protocol
title_full_unstemmed Observation on clinical effect of Huoxue-Jiangtang decoction formula granules in treating prediabetes: a randomized prospective placebo-controlled double-blind trial protocol
title_short Observation on clinical effect of Huoxue-Jiangtang decoction formula granules in treating prediabetes: a randomized prospective placebo-controlled double-blind trial protocol
title_sort observation on clinical effect of huoxue jiangtang decoction formula granules in treating prediabetes a randomized prospective placebo controlled double blind trial protocol
topic Prediabetes
Huoxue Jiangtang formula
Randomized controlled trial
Traditional Chinese medicine
url https://doi.org/10.1186/s12906-022-03755-2
work_keys_str_mv AT pengxiangzhang observationonclinicaleffectofhuoxuejiangtangdecoctionformulagranulesintreatingprediabetesarandomizedprospectiveplacebocontrolleddoubleblindtrialprotocol
AT linzeng observationonclinicaleffectofhuoxuejiangtangdecoctionformulagranulesintreatingprediabetesarandomizedprospectiveplacebocontrolleddoubleblindtrialprotocol
AT lumeng observationonclinicaleffectofhuoxuejiangtangdecoctionformulagranulesintreatingprediabetesarandomizedprospectiveplacebocontrolleddoubleblindtrialprotocol
AT huilinli observationonclinicaleffectofhuoxuejiangtangdecoctionformulagranulesintreatingprediabetesarandomizedprospectiveplacebocontrolleddoubleblindtrialprotocol
AT hengxiazhao observationonclinicaleffectofhuoxuejiangtangdecoctionformulagranulesintreatingprediabetesarandomizedprospectiveplacebocontrolleddoubleblindtrialprotocol
AT deliangliu observationonclinicaleffectofhuoxuejiangtangdecoctionformulagranulesintreatingprediabetesarandomizedprospectiveplacebocontrolleddoubleblindtrialprotocol